Aescap is an investor in life sciences companies

The Aescap group of companies manages venture capital fund Aescap I whcih consists of 7 private European companies and is establishing a new fund Aescap 2.0. Aescap 2.0 will invest in public life sciences companies.

Aescap Fund I consists of a portfolio of 7 private medical companies in Europe. The portfolio consists of high-potential companies with realistic product opportunities. This involves companies in all phases of development and commercialisation. The Fund is supported by the European Communities Growth and Employment Initiative, MAP - ETF Start up Facility. 

Aescap2.0, a new initiave, is a fund which is raising money to invest in the most promising public life sciences companies around the globe. 

Want to learn more, do not hesistate to contact us. Call Patrick Krol at +31 20 570 29 40.